HIGH
Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.
Labeling: Incorrect or Missing Lot and/or Exp Date
STAQ Pharma
Labeling: Incorrect
HIGH
Acella Pharmaceuticals Recalls Doxycycline Hyclate Tablets Over Dissolution Issue
Acella Pharmaceuticals recalled 4,680 bottles of Doxycycline Hyclate Tablets on September 29, 2025. The recall follows failed dissolution specifications, which can affect medication efficacy. This recall includes 500-count bottles distributed nationwide in the USA.
Quick Facts at a Glance
- Recall Date
- September 29, 2025
- Hazard Level
- HIGH
- Brands
- Doxycycline, Acella Pharmaceuticals
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL
Hazard Information
Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Acella Pharmaceuticals, LLC or your healthcare provider for guidance. Notification method: Letter
Product Details
The recalled product is Doxycycline Hyclate Tablets, USP 100 mg, in 500-count bottles. The lot number is P24ZLK1, with an expiration date of May 31, 2027.
The Hazard
The recall stems from stability testing that revealed the product did not meet dissolution specifications. This failure may compromise the effectiveness of the medication.
Reported Incidents
There have been no reported injuries or adverse events associated with this recall. The risk remains high due to potential ineffectiveness of the medication.
What to Do
Consumers and healthcare providers should stop using the recalled product immediately. Contact Acella Pharmaceuticals or your healthcare provider for guidance on next steps.
Contact Information
For more information, contact Acella Pharmaceuticals, LLC at their customer service line or visit their website.
Key Facts
- Recall date: September 29, 2025
- Quantity recalled: 4,680 bottles
- Distribution: Nationwide in the USA
- Hazard classification: Class II
- Expiration date: May 31, 2027
Get Alerts for Health & Personal Care Recalls
Get notified about recalls in categories you care about.
Safety Assessment
Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER
Product Classification
Product TypeDoxycycline Hyclate Tablets
Sold At
Multiple Retailers
Product Details
Model Numbers
Lot #: P24ZLK1
Exp 5/31/2027
UPC Codes
42192-501
42192-501-50
42192-501-05
Affected States
ALL
Report Date
October 15, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE
Related Recalls
HIGH
Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]
CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.
SUCRALFATE
CGMP Deviations:
HIGH
Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.
Labeling: Incorrect or Missing Lot and/or Exp Date
STAQ Pharma
Labeling: Incorrect